Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Implications of Changing the Diagnostic Criteria for Gestational Diabetes Mellitus (CDC4G) : A Healthcare Cost Analysis Alongside a Stepped Wedge Cluster Randomised Trial

de Brun, Maryam ; Johansson, Naimi ; Simmons, David ; Montgomery, Scott ; Berntorp, Kerstin LU ; Jansson, Stefan ; Wennerholm, Ulla Britt ; Wikström, Anna Karin ; Strevens, Helena LU and Ahlsson, Fredrik , et al. (2025) In BJOG: An International Journal of Obstetrics and Gynaecology
Abstract

Objective: To estimate the effect on healthcare resource use after introducing the World Health Organization diagnostic criteria (WHO-2013) for gestational diabetes mellitus (GDM) compared to former criteria in Sweden (SWE-GDM). Design: A cost-analysis alongside the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G) randomised controlled trial. Setting: Sweden, with risk-factor based screening for GDM. Population: 47 080 pregnant women and their infants. Methods: A register-based cost-analysis from a healthcare perspective alongside a stepped-wedge cluster RCT of switching from SWE-GDM to WHO-2013 criteria in 2018. Analyses were made on the population level and repeated in the subgroup affected by the intervention, that is,... (More)

Objective: To estimate the effect on healthcare resource use after introducing the World Health Organization diagnostic criteria (WHO-2013) for gestational diabetes mellitus (GDM) compared to former criteria in Sweden (SWE-GDM). Design: A cost-analysis alongside the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G) randomised controlled trial. Setting: Sweden, with risk-factor based screening for GDM. Population: 47 080 pregnant women and their infants. Methods: A register-based cost-analysis from a healthcare perspective alongside a stepped-wedge cluster RCT of switching from SWE-GDM to WHO-2013 criteria in 2018. Analyses were made on the population level and repeated in the subgroup affected by the intervention, that is, those with plasma glucose values between SWE-GDM and WHO-2013 criteria. Sensitivity analysis by bootstrapping was performed. Main Outcome Measures: Estimated costs for obstetric surveillance (including GDM-management), delivery and neonatal healthcare until 28 days postpartum. Results: On a population level, the WHO-2013 criteria were associated with increased costs of obstetric surveillance (adjusted mean [bootstrap confidence interval]) €94.0 [24.5–169.1], delivery care €20.4 [−33.5 to 75.4] and neonatal care €331.0 [75.1–589.0] per pregnancy, and in the affected subgroup €606.9 [377.7–872.4], €348.5 [126.0–542.0] and €129.3 [−559.0 to 980.9] respectively. Conclusions: Implementation of the WHO-2013 criteria in Sweden was associated with increased costs for obstetric surveillance and delivery on a population level, driven by the affected subgroup. The increased costs for neonatal care were associated with large uncertainty. A detailed understanding of the changes in resource use can guide decisions to mitigate cost increases.

(Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
epub
subject
keywords
cost analysis, diagnostic criteria, gestational diabetes mellitus, healthcare resource use
in
BJOG: An International Journal of Obstetrics and Gynaecology
publisher
Wiley-Blackwell
external identifiers
  • scopus:105015466951
  • pmid:40931348
ISSN
1470-0328
DOI
10.1111/1471-0528.18364
language
English
LU publication?
yes
id
0d34f76e-e0ea-4fde-a287-f9a741dc64b3
date added to LUP
2025-11-13 14:29:18
date last changed
2025-11-14 03:00:03
@article{0d34f76e-e0ea-4fde-a287-f9a741dc64b3,
  abstract     = {{<p>Objective: To estimate the effect on healthcare resource use after introducing the World Health Organization diagnostic criteria (WHO-2013) for gestational diabetes mellitus (GDM) compared to former criteria in Sweden (SWE-GDM). Design: A cost-analysis alongside the Changing Diagnostic Criteria for Gestational Diabetes (CDC4G) randomised controlled trial. Setting: Sweden, with risk-factor based screening for GDM. Population: 47 080 pregnant women and their infants. Methods: A register-based cost-analysis from a healthcare perspective alongside a stepped-wedge cluster RCT of switching from SWE-GDM to WHO-2013 criteria in 2018. Analyses were made on the population level and repeated in the subgroup affected by the intervention, that is, those with plasma glucose values between SWE-GDM and WHO-2013 criteria. Sensitivity analysis by bootstrapping was performed. Main Outcome Measures: Estimated costs for obstetric surveillance (including GDM-management), delivery and neonatal healthcare until 28 days postpartum. Results: On a population level, the WHO-2013 criteria were associated with increased costs of obstetric surveillance (adjusted mean [bootstrap confidence interval]) €94.0 [24.5–169.1], delivery care €20.4 [−33.5 to 75.4] and neonatal care €331.0 [75.1–589.0] per pregnancy, and in the affected subgroup €606.9 [377.7–872.4], €348.5 [126.0–542.0] and €129.3 [−559.0 to 980.9] respectively. Conclusions: Implementation of the WHO-2013 criteria in Sweden was associated with increased costs for obstetric surveillance and delivery on a population level, driven by the affected subgroup. The increased costs for neonatal care were associated with large uncertainty. A detailed understanding of the changes in resource use can guide decisions to mitigate cost increases.</p>}},
  author       = {{de Brun, Maryam and Johansson, Naimi and Simmons, David and Montgomery, Scott and Berntorp, Kerstin and Jansson, Stefan and Wennerholm, Ulla Britt and Wikström, Anna Karin and Strevens, Helena and Ahlsson, Fredrik and Sengpiel, Verena and Storck-Lindholm, Elisabeth and Persson, Martina and Petersson, Kerstin and Ursing, Carina and Ryen, Linda and Backman, Helena}},
  issn         = {{1470-0328}},
  keywords     = {{cost analysis; diagnostic criteria; gestational diabetes mellitus; healthcare resource use}},
  language     = {{eng}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{BJOG: An International Journal of Obstetrics and Gynaecology}},
  title        = {{Implications of Changing the Diagnostic Criteria for Gestational Diabetes Mellitus (CDC4G) : A Healthcare Cost Analysis Alongside a Stepped Wedge Cluster Randomised Trial}},
  url          = {{http://dx.doi.org/10.1111/1471-0528.18364}},
  doi          = {{10.1111/1471-0528.18364}},
  year         = {{2025}},
}